Pharmat SRL
The score of Pharmat shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +166 % Total assets +118 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmat's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 87,782 € | ||||
| Equity | 427,011 € | ||||
| Cash | 393,378 € | ||||
| EBITDA | 114,776 € | ||||
| Total assets | 448,864 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Pharmat's financial analysis
- Solvency95.1%sector median: 57.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmat
Pharmat's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0757.528.329
- VAT number
- BE0757528329
- Peppol
- Registered · 0208:0757528329 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Oct 2020
- Registered office
- 9100 Sint-Niklaas
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
Pharmat (SRL) has been based in Sint-Niklaas since 2020, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net profit of 87,782 € and equity of 427,011 €; its revenue is not published. Its solvency stands at 95.1%, above the median of its sector (57.1%).
Companies similar to Pharmat
Companies in the same business, of comparable size and area, outside its group.
- dochas All other professional, scientific and technical activities n.e.c. Schelle · balance sheet 423,650 €
- Effisens All other professional, scientific and technical activities n.e.c. Antwerp · balance sheet 352,151 €
- MUNT All other professional, scientific and technical activities n.e.c. Bonheiden · balance sheet 647,043 €
- Walk THE Talk All other professional, scientific and technical activities n.e.c. Oosterzele · balance sheet 293,098 €
- Tanggocharlee All other professional, scientific and technical activities n.e.c. Asse · balance sheet 284,418 €
- Hans Aerts Consulting Other information service activities Asse · balance sheet 10,951 €
- Wovamico All other professional, scientific and technical activities n.e.c. Beveren-Kruibeke-Zwijndrecht · balance sheet 274,715 €
- RLM Consulting Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 505,827 €
Frequently asked questions about Pharmat
What is the revenue of Pharmat?
Pharmat files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmat?
In Belgium, the VAT number is the company number prefixed with BE: BE0757528329 for Pharmat, if the company is VAT-registered. Its company number (CBE) is 0757.528.329.
Where is the registered office of Pharmat?
According to the CBE register, the registered office of Pharmat is in 9100 Sint-Niklaas.
What is the equity of Pharmat?
At the close of the 2025 financial year, the equity of Pharmat amounts to 427,011 €, a solvency of 95.1% of total assets.
Who manages Pharmat?
The register lists 1 active mandates at Pharmat. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmat
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →